Imidazoquinoline derivatives as adenosine A3 receptor ligands

This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.

Saved in:
Bibliographic Details
Main Author SZEREDI JUDIT,BALOGH MARIA,BATORI SANDOR,KAPUI ZOLTAN,MIKUS ENDRE,NAGY LAJOS T.,BALAZS LASZLO,BOER KINGA,URBAN-SZABO KATALIN,GERBER KATALIN,WALCZ ERZSEBET,ARANYI PETER,TIMARI GEZA
Format Patent
LanguageEnglish
Published 22.08.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention is directed to a compound of formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3 receptor ligand preferably an antagonist.
Bibliography:Application Number: CN200380106229